Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants.
Gushchin VA, Dolzhikova IV, Shchetinin AM, Odintsova AS, Siniavin AE, Nikiforova MA, Pochtovyi AA, Shidlovskaya EV, Kuznetsova NA, Burgasova OA, Kolobukhina LV, Iliukhina AA, Kovyrshina AV, Botikov AG, Kuzina AV, Grousova DM, Tukhvatulin AI, Shcheblyakov DV, Zubkova OV, Karpova OV, Voronina OL, Ryzhova NN, Aksenova EI, Kunda MS, Lioznov DA, Danilenko DM, Komissarov AB, Tkachuck AP, Logunov DY, Gintsburg AL. Gushchin VA, et al. Vaccines (Basel). 2021 Jul 12;9(7):779. doi: 10.3390/vaccines9070779. Vaccines (Basel). 2021. PMID: 34358195 Free PMC article.
Modulation of Endolysin LysECD7 Bactericidal Activity by Different Peptide Tag Fusion.
Antonova NP, Vasina DV, Rubalsky EO, Fursov MV, Savinova AS, Grigoriev IV, Usachev EV, Shevlyagina NV, Zhukhovitsky VG, Balabanyan VU, Potapov VD, Aleshkin AV, Makarov VV, Yudin SM, Gintsburg AL, Tkachuk AP, Gushchin VA. Antonova NP, et al. Among authors: gushchin va. Biomolecules. 2020 Mar 12;10(3):440. doi: 10.3390/biom10030440. Biomolecules. 2020. PMID: 32178329 Free PMC article.
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
Tkachuk AP, Bykonia EN, Popova LI, Kleymenov DA, Semashko MA, Chulanov VP, Fitilev SB, Maksimov SL, Smolyarchuk EA, Manuylov VA, Vasina DV, Gushchin VA, Gintsburg AL. Tkachuk AP, et al. Among authors: gushchin va. Vaccines (Basel). 2020 Nov 3;8(4):652. doi: 10.3390/vaccines8040652. Vaccines (Basel). 2020. PMID: 33153191 Free PMC article.
118 results